These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19080721)

  • 1. Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis.
    Simpson EL; Stevenson MD; Rawdin A; Papaioannou D
    Health Technol Assess; 2009 Jan; 13(2):iii, ix-x, 1-91. PubMed ID: 19080721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
    Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
    Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK.
    Jugrin AV; Ustyugova A; Urbich M; Lamotte M; Sunderland T
    Thromb Haemost; 2015 Oct; 114(4):778-92. PubMed ID: 26272227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.
    Simpson EL; Duenas A; Holmes MW; Papaioannou D; Chilcott J
    Health Technol Assess; 2009 Mar; 13(17):iii, ix-x, 1-154. PubMed ID: 19331797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is screening for thrombophilia cost-effective?
    Wu O; Greer IA
    Curr Opin Hematol; 2007 Sep; 14(5):500-3. PubMed ID: 17934357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis.
    Auerbach AD; Sanders GD; Hambleton J
    Am J Med; 2004 Jun; 116(12):816-28. PubMed ID: 15178497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective.
    O'Brien SH; Smith KJ
    J Pediatr; 2009 Jul; 155(1):100-4. PubMed ID: 19324372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P; Barbar S; Milan M; Vedovetto V; Pesavento R
    Eur J Intern Med; 2014 Jan; 25(1):25-30. PubMed ID: 24120221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
    Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
    Aujesky D; Smith KJ; Roberts MS
    Am J Med; 2005 Jun; 118(6):625-35. PubMed ID: 15922694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis.
    Wu O; Robertson L; Twaddle S; Lowe G; Clark P; Walker I; Brenkel I; Greaves M; Langhorne P; Regan L; Greer I;
    Br J Haematol; 2005 Oct; 131(1):80-90. PubMed ID: 16173967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombophilia testing results in patients with a first venous thromboembolic event: should the selection criteria for testing be revisited?
    Hirmerova J; Seidlerova J; Subrt I; Slechtova J
    Int Angiol; 2017 Apr; 36(2):167-173. PubMed ID: 27096232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A multicentre randomised clinical trial to evaluate the benefit of testing for thrombophilia following a first venous thromboembolism: the NOSTRADAMUS study].
    Cohn DM; Middeldorp S
    Ned Tijdschr Geneeskd; 2007 Feb; 151(6):371-3. PubMed ID: 17352304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model.
    Bond M; Mealing S; Anderson R; Elston J; Weiner G; Taylor RS; Hoyle M; Liu Z; Price A; Stein K
    Health Technol Assess; 2009 Sep; 13(44):1-330. PubMed ID: 19799825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward.
    Michiels JJ; Moosdorff W; Maasland H; Michiels JM; Lao MU; Neumann HA; Dulicek P; Stvrtinova V; Barth J; Palareti G
    Int Angiol; 2014 Feb; 33(1):1-19. PubMed ID: 24452081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilia, clinical factors, and recurrent venous thrombotic events.
    Christiansen SC; Cannegieter SC; Koster T; Vandenbroucke JP; Rosendaal FR
    JAMA; 2005 May; 293(19):2352-61. PubMed ID: 15900005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.